The coronavirus disease 2019 pandemic has had an unprecedented effect on health and health care and posed challenges to the conduct of clinical trials.Targeted mitigating strategies, on the basis of early and continued data collection from site surveys, limited disruption to the ASCEND trials.Flexibly allowing hemoglobin assessment at local laboratories to inform randomized treatment dosing was key to limiting the discontinuation of treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136902 | PMC |
| http://dx.doi.org/10.34067/KID.0006212021 | DOI Listing |
Publication Analysis
Top Keywords
challenges conducting
4
conducting clinical
4
clinical trials
4
trials sars-cov-2
4
sars-cov-2 pandemic
4
pandemic ascend
4
ascend global
4
global program
4
program experience
4
experience coronavirus
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!